Sign in

CIK 0001936258

  • Large accelerated filer

NewAmsterdam Pharma Co N.V.

Sign in to watch
Ticker
NAMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Netherlands
Entity type
Operating
Phone
35 206 2971
Business address
GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
Former names
NewAmsterdam Pharma Co B.V.

Securities

  • NAMS Ordinary Shares Nasdaq
  • NAMSW Warrant Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Planned sale 10% owner sold 29,846 shares at $25.54 ($762,174)
  5. 4 Planned sale 10% owner sold 74,910 shares at an average $25.98 ($1,945,918)
  6. 4 Planned sale 10% owner sold 91,068 shares at an average $25.58 ($2,329,520)
  7. 4 Planned sale 10% owner sold 157,234 shares at an average $25.86 ($4,066,714)
  8. 4 Planned sale 10% owner sold 115,480 shares at an average $25.95 ($2,996,156)
  9. 4 Derivatives Options or other derivatives
  10. 4 Planned sale 10% owner sold 191,762 shares at an average $25.34 ($4,859,875)
  11. 4 Planned sale 10% owner sold 462,288 shares at an average $25.40 ($11,740,618)
  12. 4 Planned sale 10% owner sold 41,803 shares at an average $25.07 ($1,047,876)
  13. 4 Planned sale 10% owner sold 10,898 shares at an average $25.01 ($272,511)
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market sale Chief Accounting Officer sold 45,000 shares at $15.72 ($707,400)
  16. 4 Open-market buy Chief Business Officer bought 1,104 shares at $15.70 ($17,333)
  17. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $16.27 ($81,350)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 5 of 7 · 132 filings